Table 2 Demographics and clinical characteristics.
From: Intraventricular antibiotics for severe central nervous system infections: a case series
Overall | CA-CNSI | HAVM | p-Value | |
|---|---|---|---|---|
Number | 27 | 13 | 14 | |
Sex (n = female, (%)) | 14 (51.9) | 7 (53.8) | 7 (50.0) | 1.000 |
Age (as years, mean (SD)) | 54.1 (15.6) | 47.9 (16.2) | 59.9 (13.1) | 0.045 |
CCI (median [IQR]) | 2 [0.5 – 4] | 1 [0 – 5] | 1.5 [1 – 4] | 0.921 |
SAPS II (mean (SD)) | 43.6 (15.0) | 41.5 (16.4) | 45.9 (13.7) | 0.470 |
GCS at hospital admission (median [IQR]) | 9 [5.5 – 13] | 10 [7 – 12] | 8 [4– 13.75] | 0.507 |
GCS at NCCU admission (median [IQR]) | 3 [3 – 4] | 3 [3 – 4] | 3 [3 – 4] | 0.705 |
Seizures | 0.822 | |||
None (n (%)) | 14 (51.9) | 6 (46.2) | 8 (57.1) | |
Focal (n (%)) | 6 (22.2) | 3 (23.1) | 3 (21.4) | |
Generalised (n (%)) | 7 (25.9) | 4 (30.8) | 3 (21.4) | |
Status Epilepticus | 0.564 | |||
None (n (%)) | 22 (81.5) | 10 (76.9) | 12 (85.7) | |
Focal (n (%)) | 1 (3.7) | 1 (7.7) | 0 (0) | |
Generalised (n (%)) | 4 (14.8) | 2 (15.4) | 2 (14.3) |
